Limits...
Design of the e-Vita diabetes mellitus study: effects and use of an interactive online care platform in patients with type 2 diabetes (e-VitaDM-1/ZODIAC-40).

Roelofsen Y, Hendriks SH, Sieverink F, van Vugt M, van Hateren KJ, Snoek FJ, de Wit M, Gans RO, Groenier KH, van Gemert-Pijnen JE, Kleefstra N, Bilo HJ - BMC Endocr Disord (2014)

Bottom Line: Empowering patients through an online care platform could help to improve patients' self-management and reduce the burden on the healthcare system.Platform usage will be tracked and compared.Although providing access to a online platform is not a novel intervention, usage and effects have not yet been studied in this patient population.

View Article: PubMed Central - HTML - PubMed

Affiliation: Diabetes Centre, Isala, Zwolle, The Netherlands. y.roelofsen@isala.nl.

ABSTRACT

Unlabelled: Trial registration: NCT01570140.

Background: Due to ongoing rise in need for care for people with chronic diseases and lagging increase in number of care providers, alternative forms of care provision and self-management support are needed. Empowering patients through an online care platform could help to improve patients' self-management and reduce the burden on the healthcare system.

Methods: Access to laboratory results and educational modules on diabetes will be offered through a platform for subjects with type 2 diabetes mellitus treated in primary care. Differences in socio-demographic and clinical characteristics between subjects expressing interest vs. disinterest to use the platform will be explored. Platform usage will be tracked and compared. Patient satisfaction and quality of life will be measured by validated questionnaires and economic analyses will be performed.

Discussion: This study is designed to assess the feasibility of use of an online platform in routine primary healthcare for subjects with type 2 diabetes mellitus in the Netherlands, and to study effects of use of the platform on treatment satisfaction, quality of life and clinical parameters. Although providing access to a online platform is not a novel intervention, usage and effects have not yet been studied in this patient population.

No MeSH data available.


Related in: MedlinePlus

Patient flow.
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
getmorefigures.php?uid=PMC4016215&req=5

Figure 1: Patient flow.

Mentions: A prospective observational study of patients volunteering to use the interactive care platform (e-VitaDM), within the ZODIAC study (see Figure 1). Nested in this observational study a randomized controlled trial is planned testing coaching vs. non-coaching of a self-management support module (see Figure 2) [12].


Design of the e-Vita diabetes mellitus study: effects and use of an interactive online care platform in patients with type 2 diabetes (e-VitaDM-1/ZODIAC-40).

Roelofsen Y, Hendriks SH, Sieverink F, van Vugt M, van Hateren KJ, Snoek FJ, de Wit M, Gans RO, Groenier KH, van Gemert-Pijnen JE, Kleefstra N, Bilo HJ - BMC Endocr Disord (2014)

Patient flow.
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
Show All Figures
getmorefigures.php?uid=PMC4016215&req=5

Figure 1: Patient flow.
Mentions: A prospective observational study of patients volunteering to use the interactive care platform (e-VitaDM), within the ZODIAC study (see Figure 1). Nested in this observational study a randomized controlled trial is planned testing coaching vs. non-coaching of a self-management support module (see Figure 2) [12].

Bottom Line: Empowering patients through an online care platform could help to improve patients' self-management and reduce the burden on the healthcare system.Platform usage will be tracked and compared.Although providing access to a online platform is not a novel intervention, usage and effects have not yet been studied in this patient population.

View Article: PubMed Central - HTML - PubMed

Affiliation: Diabetes Centre, Isala, Zwolle, The Netherlands. y.roelofsen@isala.nl.

ABSTRACT

Unlabelled: Trial registration: NCT01570140.

Background: Due to ongoing rise in need for care for people with chronic diseases and lagging increase in number of care providers, alternative forms of care provision and self-management support are needed. Empowering patients through an online care platform could help to improve patients' self-management and reduce the burden on the healthcare system.

Methods: Access to laboratory results and educational modules on diabetes will be offered through a platform for subjects with type 2 diabetes mellitus treated in primary care. Differences in socio-demographic and clinical characteristics between subjects expressing interest vs. disinterest to use the platform will be explored. Platform usage will be tracked and compared. Patient satisfaction and quality of life will be measured by validated questionnaires and economic analyses will be performed.

Discussion: This study is designed to assess the feasibility of use of an online platform in routine primary healthcare for subjects with type 2 diabetes mellitus in the Netherlands, and to study effects of use of the platform on treatment satisfaction, quality of life and clinical parameters. Although providing access to a online platform is not a novel intervention, usage and effects have not yet been studied in this patient population.

No MeSH data available.


Related in: MedlinePlus